Adaptive Biotechnologies is trading 4.52% lower at $28.10 on September 28, with no clear company-specific catalyst identified as broader markets decline.
- The S&P 500, Nasdaq Composite and Dow Jones are each down more than 0.5% amid rising oil prices, Treasury yields and geopolitical concerns.
- A September 28 report covered a CPO stock sale, but the transactions occurred September 16 under a pre-existing trading plan, so the report does not establish a direct cause of today’s drop.